1. Blocking soluble TNFα sensitizes HER2-positive breast cancer to trastuzumab through MUC4 downregulation and subverts immunosuppression. Issue 3 (8th March 2023) Authors: Bruni, Sofia; Mauro, Florencia L; Proietti, Cecilia J; Cordo-Russo, Rosalia I; Rivas, Martin A; Inurrigarro, Gloria; Dupont, Agustina; Rocha, Dario; Fernández, Elmer A; Deza, Ernesto Gil; Lopez Della Vecchia, Daniel; Barchuk, Sabrina; Figurelli, Silvina; Lasso, David; Friedrich, Adrián D; Santill... Journal: Journal for immunotherapy of cancer Issue: Volume 11:Issue 3(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗